|

CytOSorb TreatMent Of Critically Ill PatientS Registry

RECRUITINGSponsored by CytoSorbents, Inc
Actively Recruiting
SponsorCytoSorbents, Inc
Started2022-06-22
Est. completion2032-06
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05146336

Summary

Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

1. Planned OR actual CytoSorb® 300 mL device utilization
2. Informed consent for prospective registry participation

Exclusion Criteria:

1. Use of the CytoSorb® 300 mL device for antithrombotic removal only
2. Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only
3. The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate.

Conditions20

Acute Liver FailureAcute Respiratory Distress SyndromeAcute on Chronic Liver FailureBurnsCardiogenic ShockChimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)Drug OverdoseExtracorporeal Life SupportHeart DiseaseHemophagocytic Lymphohistiocytoses

Browse More Trials

Heart Disease trialsLiver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.